Chronic Low Back Pain and Neck Pain Prospective Study
A Prospective Study to Identify New "Omics" and Imaging Biomarkers of Chronic/Persistent Neck and Low Back Pain
1 other identifier
observational
800
1 country
1
Brief Summary
This prospective observation multifaceted study aims:
- 1.To perform a large prospective study and identify multiple "omics" biomarkers in chronic low back pain
- 2.To validate identified biomarkers for progression of acute to chronic low back pain
- 3.To validate identified biomarkers and test their heritability/validity in additional cohorts
- 4.To identify pathways and relevant individual variations for generation, propagation and subsidence of pain
- 5.To identify new imaging biomarkers related to chronic low back pain
- 6.To develop a registry of neck and low back pain subjects to help monitor the health-care management and utility to improve protocols and patient outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2015
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2015
CompletedFirst Submitted
Initial submission to the registry
April 26, 2021
CompletedFirst Posted
Study publicly available on registry
May 12, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedApril 29, 2026
April 1, 2026
10.2 years
April 26, 2021
April 27, 2026
Conditions
Outcome Measures
Primary Outcomes (2)
Radiographic assessment
assess the subjects' standing X-ray of the whole spine (AP and lateral) for the presence and extent of atherosclerosis, endplate thickening (sclerosis), vertebral osteophytes, limbus vertebrae, presence and categorization of vertebral subluxation (spondylolisthesis), additional spine-related deformities, spinal canal and vertebral body/foraminal dimensions, and static/dynamic spinal motion parameters and alignments. This will be done at interval follow-ups
Change up to 60-months follow-up
MRI assessment
MRI: Sagittal T2W MRI whole spine and axial T1W MRI of lumbar spine will be assessed in all subjects. The radiographic events/outcomes of interest entailed the presence and extent of disc degeneration, disc bulges/herniations, Schmorl's nodes (endplate irregularities), high-intensity zones (HIZ), and bone marrow signal changes involving the endplate. Interval assessments will be made.
Change up to 60-months follow-up
Secondary Outcomes (9)
Oswestry Disability index
Change to 60-months follow-up
Neck disability index
Change to 60-months follow-up
Neck pain disability scale
Change to 60-months follow-up
Depression-Anxiety Stress Scale
Change to 60-months follow-up
SF-36
Change to 60-months follow-up
- +4 more secondary outcomes
Study Arms (1)
Chronic Low Back Pain and Neck Pain
Interventions
Eligibility Criteria
Patients were referred to the specialist orthopaedic clinic
You may qualify if:
- Neck and/or low back pain
- New cases\*
- Males and females
- years or older
- Willing to participate in the study short- and long-term
You may not qualify if:
- Previous spine surgery
- Cognitively impaired
- Drug addiction
- Incarceration (prisoner)
- History of infections, tumors, chronic inflammation (e.g. rheumatoid arthritis, ankylosing spondylitis)
- Congenital/syndromal
- Pregnant females
- Diagnosed psychological impairment
- Inability to read or write
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Queen Mary Hospital
Hong Kong, Hong Kong
Biospecimen
Tests for low density lipoprotein (LDL), high density lipoprotein (HDL), cholesterol counts, triglycerides, erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), metabolomics, glycomics, CCL5/CCL6 and adipokines.
Study Officials
- PRINCIPAL INVESTIGATOR
Dr. Jason Cheung
The University of Hong Kong/ Queen Mary Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Associate Professor
Study Record Dates
First Submitted
April 26, 2021
First Posted
May 12, 2021
Study Start
May 1, 2015
Primary Completion
June 30, 2025
Study Completion
December 31, 2025
Last Updated
April 29, 2026
Record last verified: 2026-04